Skip to main content
. 2017 Jul 17;12(7):e0180768. doi: 10.1371/journal.pone.0180768

Table 1. Age, gender, ABO group, dietary and vaccination histories, and geographic area of childhood in 84 healthy human subjects from whom sera were studied in the present report.

N = 84; average age = 35.6y
Age 20–29 = 26.2% (22/84); 30–39 = 45.2% (38/84); 40–49 = 22.6% (19/84); 50–59 = 4.8% (4/84); 60–80 = 1.2% (1/84)
Gender M = 69% (58/84), mean age 34.1 y. F = 31% (26/84), mean age 36.3 y
ABO blood group A = 33.3% (28/84), B = 22.6% (19/84), O = 38.1% (32/84), AB = 6.0% (5/84)
Diet Vegetarians = 2.4% (2/84), NO white meat = 2.4% (2/84), NO beef = 6.0% (5/84), NO pork = 17.9% (15/84).
 Vaccination history Bacillus Calmette-Guerin Y = 69.8% (58/84), N = 30.2% (26/84)
Diphtheria, Pertussis, Tetanus Y = 96.4% (81/84), N = 3.6% (3/84)
Haemophilus influenzae type B Y = 22.6% (19/84), N = 77.4% (65/84)
Hepatitis B Y = 83.3% (70/84), N = 16.7% (14/84)
Influenza Y = 72.6% (61/84), N = 27.4% (23/84)
Measles Y = 89.3% (75/84), N = 10.7% (9/84)
Measles, Mumps, Rubella Y = 90.5% (76/84), N = 9.5% (8/84)
Oral Poliomyelitis Vaccine Y = 88.1% (74/84), N = 11.9% (10/84)
Typhoid Y = 25.0% (21/84), N = 75.0% (63/84)
Varicella Zoster Y = 35.7% (30/84), N = 64.3% (54/84)
Yellow Fever Y = 20.2% (17/84), N = 79.8% (67/84)
Geographic location during childhood Europe: 17.9% (15/84); Middle-East: 13.1% (11/84); Africa: 2.4% (2/84); South-West Asia: 8.3% (7/84); East Asia: 32.1% (27/84); South America: 9.5% (8/84); North America: 16.7% (14/84)

M = male; F = female; Y = yes; N = no.

HHS Vulnerability Disclosure